What is she best known for?
The fields of study she is best known for:
- Gene
- Enzyme
- Internal medicine
Cristina Limatola mainly investigates Neuroscience, Cell biology, CX3CR1, Microglia and Neuroprotection.
Her biological study spans a wide range of topics, including Chemokine, Long-term potentiation and Neurotransmission.
She has researched Cell biology in several fields, including Cerebellum, Interleukin 15, Chemokine receptor and Neurotransmitter.
The study incorporates disciplines such as Hippocampus and Adenosine A1 receptor in addition to CX3CR1.
Her Microglia study integrates concerns from other disciplines, such as Dendritic spine, Axon, In vivo and Cognitive decline.
Her biological study spans a wide range of topics, including Neurotoxicity and Adenosine.
Her most cited work include:
- Dark microglia: A new phenotype predominantly associated with pathological states (168 citations)
- Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells (146 citations)
- Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. (134 citations)
What are the main themes of her work throughout her whole career to date?
Neuroscience, Cell biology, Microglia, Receptor and Internal medicine are her primary areas of study.
Her studies in Neuroscience integrate themes in fields like CX3CR1, CX3CL1 and Neurotransmission.
Her research in Cell biology intersects with topics in Glutamate receptor, Chemokine, Chemokine receptor, CXC chemokine receptors and Stimulation.
Her studies deal with areas such as Neuroinflammation, Neurodegeneration, Immune system and Glioma as well as Microglia.
Her study looks at the intersection of Receptor and topics like Microtransplantation with Human brain.
Her work focuses on many connections between Internal medicine and other disciplines, such as Endocrinology, that overlap with her field of interest in Acetylcholine receptor and Long-term potentiation.
She most often published in these fields:
- Neuroscience (33.33%)
- Cell biology (25.29%)
- Microglia (22.41%)
What were the highlights of her more recent work (between 2017-2021)?
- Microglia (22.41%)
- Neuroscience (33.33%)
- Cell biology (25.29%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Microglia, Neuroscience, Cell biology, Glioma and Cancer research.
The Microglia study combines topics in areas such as Neuroinflammation, Neurodegeneration and Endocrinology.
Her Neuroscience research incorporates elements of NMDA receptor and Disease.
Her study on NMDA receptor also encompasses disciplines like
- Receptor most often made with reference to Parvalbumin,
- Neurotransmission that connect with fields like AMPA receptor.
Her work investigates the relationship between Cell biology and topics such as Cell that intersect with problems in Cerebral cortex, Tris and Catenin.
Her Cancer research research incorporates themes from Tumor microenvironment, Brain tumor, Phenotype and In vivo.
Between 2017 and 2021, her most popular works were:
- Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model (51 citations)
- Microglia shape presynaptic properties at developing glutamatergic synapses (29 citations)
- CXCL16/CXCR6 axis drives microglia/macrophages phenotype in physiological conditions and plays a crucial role in glioma (25 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Her primary scientific interests are in Microglia, Neuroscience, Cell biology, Glioma and Neuroprotection.
Her Microglia research includes elements of Neuroimmunology, Neuroinflammation, Amyotrophic lateral sclerosis and Neurodegeneration.
She combines subjects such as Immune system and FOXP3 with her study of Neuroscience.
Her work on Catenin and Wnt signaling pathway as part of general Cell biology study is frequently connected to Dishevelled and Nuclear protein, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Glioma research is multidisciplinary, incorporating elements of Phenotype, Downregulation and upregulation and Nervous system.
Her Neuroprotection research is multidisciplinary, relying on both Chemokine, CX3CL1 and CXCL16.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
